![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Sustained Virologic Response With Daclatasvir Plus Sofosbuvir ± Ribavirin (RBV) in Chronic HCV Genotype (GT) 1-Infected Patients Who Previously Failed Telaprevir (TVR) or Boceprevir (BOC)
|
|
|
Reported by Jules Levin
APASL Liver Week 2013: The 2013 Annual Meeting of the
Asian Pacific Association for the Study of the Liver
Singapore, June 6-10, 2013
Sulkowski MS, Gardiner DF, Rodriguez-Torres M, Reddy KR, Hassanein T, Jacobson IM, Lawitz E, Lok AS, Hinestrosa F, Thuluvath PJ, Schwartz H, Nelson DR, Everson GT, Eley T, Wind-Rotolo M, Huang S-P, Gao M, Hernandez D, McPhee F, Sherman D, Hindes R, Symonds W, Pasquinelli C, and Grasela DM for the AI444-040 Study Group
![APASL1.gif](../images/062513/062513-3/APASL1.gif)
![APASL2.gif](../images/062513/062513-3/APASL2.gif)
![APASL3.gif](../images/062513/062513-3/APASL3.gif)
![APASL4.gif](../images/062513/062513-3/APASL4.gif)
![APASL5.gif](../images/062513/062513-3/APASL5.gif)
![APASL6.gif](../images/062513/062513-3/APASL6.gif)
![APASL7.gif](../images/062513/062513-3/APASL7.gif)
![APASL8.gif](../images/062513/062513-3/APASL8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|